Condition: Breast Cancer · Oligometastasis · Sponsor: xuexin he
A Randomized, Open Label, Phase III Trial to Evaluate Radical Local Treatment versus Palliative Treatment for Breast Cancer Patients with Primary Ipsilateral Humerus or Sternum Oligometastasis
This description comes directly from the study's public registry record.
xuexin he, MD · +86-18329139569 · xuexinhe@zju.edu.cn
Always discuss trial participation with your own doctor first.
| Institute of Cancer Research and Basic Medical Sciences, CAS Cancer Hospital, University of Chinese Academy of Sciences Zhejiang Cancer Hospital | Hangzhou, Zhejiang, China | Not Yet Recruiting |
| The Second Affiliated Hospital of Zhejiang University School of Medicine (SAHZU) | Hangzhou, Zhejiang, China | Recruiting |
| Jiaxing Second Hospital | Jiaxing, Zhejiang, China | Not Yet Recruiting |
| The Central Hospital of Lishui | Lishui, Zhejiang, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04158843